Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine · generic available

Bacitracin zinc and polymyxin b sulfate

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Bacitracin zinc and polymyxin b sulfate key facts

Used for
For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate. (source)
Prescription or over the counter
Prescription (Rx) · some products also sold over the counter
Generic available
Yes
Typical pharmacy cost
$2.82 per gram (bacitracin zinc 500 USP units/g · polymyxin b sulfate 10000 USP units/g; NADAC)
Latest FDA recall
None listed

Sources: FDA label (March 17, 2026); FDA NDC Directory (November 13, 2026); CMS NADAC (November 11, 2026); FDA enforcement reports (November 10, 2026). Not medical advice.

Quick answers

What is Bacitracin zinc and polymyxin b sulfate used for?
The FDA-approved label (Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, March 17, 2026) says: “For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
What are the side effects of Bacitracin zinc and polymyxin b sulfate?
The “Adverse Reactions” section of the FDA label (Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, March 17, 2026) begins: “To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Bacitracin zinc and polymyxin b sulfate have a boxed warning?
No. None of the 5 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Bacitracin zinc and polymyxin b sulfate?
No current shortage is listed by the FDA for the products of this medicine (FDA data from November 13, 2026).
Has Bacitracin zinc and polymyxin b sulfate been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Bacitracin zinc and polymyxin b sulfate?
3 companies list prescription products of Bacitracin zinc and polymyxin b sulfate in the FDA NDC Directory, including A-S Medication Solutions, NuCare Pharmaceuticals, Inc. and Bausch & Lomb Incorporated.

What Bacitracin zinc and polymyxin b sulfate is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate.

— FDA label: Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, effective March 17, 2026. Read the full label on DailyMed →

Label quoted: the one for the most common form (ointment, ophthalmic), Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions; it covers 1 product in the FDA NDC Directory. The side effects, interactions, dosage and pregnancy quotes below come from this same label.

The FDA has 5 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

0 of 5 FDA labels for this medicine have a boxed warning.

Bacitracin zinc and polymyxin b sulfate side effects

Quoted from the “Adverse Reactions” section of the FDA-approved label. Tell your doctor about any side effect that worries you.

To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

— FDA label: Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, effective March 17, 2026. Read the full label on DailyMed →

Bacitracin zinc and polymyxin b sulfate dosage

Quoted from the “Dosage and Administration” section of the FDA-approved label. Your own dose is the one your doctor prescribes: do not change it on your own.

Apply the ointment every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection. FOR OPHTHALMIC USE ONLY

— FDA label: Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, effective March 17, 2026. Read the full label on DailyMed →

When Bacitracin zinc and polymyxin b sulfate should not be used

Quoted from the “Contraindications” section of the FDA-approved label.

This product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

— FDA label: Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, effective March 17, 2026. Read the full label on DailyMed →

Forms and how it is given

Dosage formsOintment
RouteOphthalmic
Prescription products5 in the FDA NDC Directory
Brand namesPolycin

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Bacitracin zinc and polymyxin b sulfate, by strength and form
Strength and formGeneric or brandPharmacies pay
bacitracin zinc 500 USP units/g · polymyxin b sulfate 10000 USP units/g
ointment
Generic $2.82 per gram

NADAC list of November 11, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.

Generic approvals (2)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)213621, 308511
SPL set ID of the quoted label51f6eac3-205e-4beb-8522-6ba2c593f350
FDA labels (SPL)5
FDA applications2 ANDA
Active ingredients (FDA)BACITRACIN ZINC / POLYMYXIN B SULFATE

Next steps

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, effective March 17, 2026; via openFDA, FDA data exported November 13, 2026, retrieved November 14, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers